Chlorpheniramine Maleate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 14 USDMF, 2 JDMF, 5 EU WC, 5 KDMF, 12 NDC API, 28 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

203 FDF Dossiers, 66 FDA Orange Book, 8 Europe, 34 Canada, 26 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 4MG/5ML;5MG/5ML, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 12 Rochem International Inc, 23 SPI Pharma, 2 Seqens, 27 DKSH, 2 Jai Radhe Sales, 3 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 17 Gangwal Healthcare, 2 Kewpie Corporation, 15 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 14 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 5 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 4 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

124 Fillers, Diluents & Binders, 73 Coating Systems & Additives, 63 Thickeners and Stabilizers, 55 Direct Compression, 52 Solubilizers, 45 Taste Masking, 44 Disintegrants & Superdisintegrants, 43 Controlled & Modified Release, 34 Topical, 33 Parenteral, 33 Granulation, 31 Film Formers & Plasticizers, 29 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 22 Co-Processed Excipients, 17 Rheology Modifiers, 16 Emulsifying Agents, 13 API Stability Enhancers, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

MARKET PLACE

25 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 8 JP, 1 Others

Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Enforcement Report - Week of July 31, 2019

31 Jul 2019

// FDA

Capellon Pharms’ Generic Dexchlorpheniramine Maleate Receives Approval In The US

21 Jul 2018

// FDA

Vernalis and Tris' Tuzistra (Codeine Polistirex and Chlorpheniramine Polistirex) Approved in USA For Cough

05 May 2015

// Press Release VERNALIS

Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

02 May 2015

// Eric Palmer FIERCE PHARMA MFG

Digital Content for (+)-Chlorpheniramine maleate

Chlorpheniramine Maleate

Chlorpheniramine Maleate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers

14 USDMF

2 JDMF

5 EU WC

5 KDMF

12 NDC API

28 Listed Suppliers

$ API Reference Price

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

203 FDF Dossiers

66 FDA Orange Book

8 Europe

34 Canada

26 South Africa

69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 4MG/5ML;5MG/5ML

TABLET;ORAL - 2MG;200MG;30MG

TABLET;ORAL - 4MG;200MG;10MG

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

12 Rochem International Inc

23 SPI Pharma

2 Seqens

27 DKSH

2 Jai Radhe Sales

3 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

17 Gangwal Healthcare

2 Kewpie Corporation

15 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

14 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

37 BASF

1 Bioplus Life Sciences

5 Clariant

14 Corel Pharma Chem

7 DFE Pharma

2 Finar

14 Gangwal Chemicals

11 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

4 Kima Chemical

6 Lonza Capsugel

22 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

47 Roquette

14 Seppic

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 12MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons